Breast cancer cells with doubled genomes may dodge immunotherapy by turning off key immune signals

Whole-genome doubling (WGD) promotes immune suppression in breast cancer. WGD+ tumors exhibit a reduced response to IFNγ and decreased expression of antigen-presentation…

Continue Reading


News Source: medicalxpress.com

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *